1-20 of 24
Chantal Himberlin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Switch of Asparaginase Formulation Based on Antibody Monitoring in Adults with Philadelphia-Negative Adult Lymphoblastic Leukemia. Results of the Graall-2014 Trial

Marie Balsat, Corentin Orvain, Jean-François Benoist, Nicolas De Roux, Thibaut Leguay, Françoise Huguet, Patrice Chevallier, Cendrine Josson, Christine Bain-Wendlinger, Yosr Hicheri, Anne Thiebaut, Martine Escoffre-Barbe, Thomas Cluzeau, Florence Pasquier, Ana Berceanu, Florence Van Obbergh, Jamilé Frayfer, Gaëlle Guillerm, Victoria Cacheux, Isabelle Plantier, Laurence Sanhes, Chantal Himberlin, Jacques Vargaftig, Sabine Tricot, Yves Chalandon, Carlos Graux, Véronique Lheritier, Hervé Dombret, Hunault-Berger Mathilde, Nicolas Boissel
Journal: Blood
Blood (2024) 144 (Supplement 1): 1434.
https://doi.org/10.1182/blood-2024-199110
Published: 2024
Journal Articles

Dexaml-02 : A Phase II Study of Dexamethasone Added to Induction and Postremission Therapy in Older Patients with Newly Diagnosed AML. a French Innovative Leukemia Organization (FILO) Study

Christian Recher, Sarah Bertoli, Pierre Peterlin, Romain Guieze, Yohan Desbrosses, Yosr Hicheri, Omar Benbrahim, Martin Carre, Hunault-Berger Mathilde, Anne Banos, Marc Bernard, Emmanuel Gyan, Alain Saad, Safia Chebrek, Gabrielle Roth Guepin, Veronique Dorvaux, Laurence Sanhes, Maria Pilar Gallego Hernanz, Carole Exbrayat, Laure Vincent, Chantal Himberlin, Laetitia Largeaud, Eric Delabesse, Francois Vergez, Norbert Vey, Ariane C Mineur, Célestine Simand, Isabelle Luquet, Arnaud Pigneux
Journal: Blood
Blood (2022) 140 (Supplement 1): 6149–6151.
https://doi.org/10.1182/blood-2022-158665
Published: 2022
Journal Articles

Gilteritinib Activity in Refractory or Relapsed FLT3 -Mutated Acute Myeloid Leukemia Patients Previously Treated By Intensive Chemotherapy and Midostaurin: A Study from the French AML Intergroup ALFA/Filo

Pierre-Yves Dumas, Emmanuel Raffoux, Emilie Berard, Sarah Bertoli, Marie Anne Hospital, Mael Heiblig, Yohan Desbrosses, Caroline Bonmati, Cecile Pautas, Juliette Lambert, Corentin Orvain, Anne Banos, Florence Pasquier, Pierre Peterlin, Tony Marchand, Madalina Uzunov, Jamilé Frayfer, Pascal Turlure, Thomas Cluzeau, Eric Jourdan, Chantal Himberlin, Emmanuelle Tavernier, Alban Villate, Stéphanie Haiat, Marie-Lorraine Chretien, Martin Carre, Sylvain Chantepie, Iona Vaida, Mathieu Wemeau, Safia Chebrek, Gaëlle Guillerm, Romain Guieze, Houria Debarri, Eve Gehlkopf, Kamel Laribi, Ambroise Marçais, Alberto Santagostino, Marie C Bene, Ariane C Mineur, Arnaud Pigneux, Herve Dombret, Christian Recher
Journal: Blood
Blood (2022) 140 (Supplement 1): 8996–8998.
https://doi.org/10.1182/blood-2022-159125
Published: 2022
Journal Articles

Long-Term Survival of Acute Myeloid Leukemia Responding Patients Who Stopped Azacytidine and/or Venetoclax Because of Poor Tolerance or Physician Choice: A Retrospective Multicenter Study from the French Innovative Leukemia Organization (FILO)

Sylvain Garciaz, Justine Decroocq, Sarah Bertoli, Amine Belhabri, Pierre-Yves Dumas, Celestine Simand, Kamel Laribi, Alberto Santagostino, Martin Carre, Aline Schmidt, Gaspard Aspas Requena, Chantal Himberlin, Marie-Anne Hospital, Christian Recher, Norbert Vey
Journal: Blood
Blood (2022) 140 (Supplement 1): 6147–6148.
https://doi.org/10.1182/blood-2022-158247
Published: 2022
Journal Articles

Comparison of a Combination of Vosaroxin (VOS) and Intermediate-Dose Cytarabine (IDAC) with Idac for the Consolidation Therapy of Younger Patients with Favorable- and Intermediate-Risk Acute Myeloid Leukemia (AML) in First Complete Remission (CR): Preliminary Results of a Randomized Phase 2 R4-VOS Study of the French ALFA-Filo AML Intergroup

Norbert Vey, MD, Corentin Orvain, MD PhD, Christian Recher, MD PhD, Arnaud Pigneux, MD PhD, Marc Bernard, MD, Anne Banos, MD, Pierre Peterlin, MD, Sylvain Chantepie, MD, Xavier Thomas, MD PhD, Cecile Pautas, MD, Claude Gardin, Emilie Lemasle, MD, Emmanuel Raffoux, MD, Romain Guieze, MD, Chantal Himberlin, MD, Clémence Loiseau, MD, Amine Belhabri, MD, Isabelle Luquet, MD, Christine Terré, PharmD, PhD, Martin Carre, MD, Claude Preudhomme, MD PhD, Eric Delabesse, MD PhD, Karine Celli-Lebras, CRA, Ariane C Mineur, CRA, Jean-Francois Brasme, MD PhD, Jean Francois Hamel, MD, Hervé Dombret, MD, Mathilde Hunault, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-137032
Published: 2020
Journal Articles

Very Long Term Follow up a Phase II Study of Post-Remission Subcutaneous (SC) Azacitidine (AZA) in Patients with AML Post-MDS or Higher-Risk (HR) MDS

Amina Cherait, Thorsten Braun, MD PhD, Krimo Bouabdallah, MD, Denis Caillot, Agnès Guerci, MD PhD, Emmanuel Raffoux, MD, Jean Pierre Marolleau, Cecile Pautas, MD, Anne Banos, MD, Chantal Himberlin, MD, Anne Laure Taksin, Arnaud Pigneux, MD PhD, Xavier Thomas, MD PhD, Norbert Vey, MD, Sylvie Chevret, MDPhD, Herve Dombret, MD PhD, Fatiha Chermat, Lionel Ades, MDPhD, Claude Gardin, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-137012
Published: 2020
Journal Articles

Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements

Ilaria Tanasi, Ibrahima Ba, Nicolas Sirvent, Thorsten Braun, Wendy Cuccuini, Paola Ballerini, Nicolas Duployez, Aline Tanguy-Schmidt, Jérôme Tamburini, Sébastien Maury, Eric Doré, Chantal Himberlin, Cédric Duclos, Patrice Chevallier, Philippe Rousselot, Massimiliano Bonifacio, Hélène Cavé, André Baruchel, Hervé Dombret, Jean Soulier, Judith Landman-Parker, Nicolas Boissel, Emmanuelle Clappier
Journal: Blood
Blood (2019) 134 (16): 1351–1355.
https://doi.org/10.1182/blood.2019001244
Published: 2019
Includes: Supplemental data
Journal Articles

Nilotinib (Tasigna ® ) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1- Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)

Oliver G. Ottmann, MD, Heike Pfeifer, MD, Jean-Michel Cayuela, PhD, Karsten Spiekermann, MD, Wolfram Jung, MD, Joachim Beck, Emmanuel Raffoux, MD, Pascal Turlure, MD, Chantal Himberlin, Francoise Huguet, MD, Andreas Viardot, MD, Knut Wendelin, MD, Albrecht Reichle, MD, Sébastien Maury, MD PhD, Laurence Sanhes, MD, Francoise Isnard, PhD, Jean-Yves Cahn, MD, Stephane Lepretre, Patrice Chevallier, MD, Martine Escoffre-Barbe, MD, Josep-Maria Ribera, MD PhD, Dieter Hoelzer, MD PhD, Nicola Goekbuget, MD, Hervé Dombret, Philippe Rousselot, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 31.
https://doi.org/10.1182/blood-2018-99-114552
Published: 2018
Journal Articles

Safety and Long-Term Efficacy of Maintenance Therapy with Alternating Azacytidine (AZA) and Lenalidomide (Len) Cycles in Elderly (≥ 60) Fit Patients (Pts) with Poor Prognosis AML in First Complete Remission (CR) After LIA Induction. A Phase II Multicentric GOELAMS Trial

Mathilde Hunault, MD PhD, Nathalie Maillard, MD, Aline Tanguy-Schmidt, MD, Chantal Himberlin, MD, Bachra Choufi, MD, Caroline Bonmati, MD, Marie Anne Couturier, MD, Eric Deconinck, MD PhD, Jean Pierre Marolleau, MD PhD, Frédérique Orsini-Piocelle, MD, Jacques Delaunay, MD, Emmanuelle Tavernier, MD, Christian Récher, MDPhD, Severine Lissandre, MD, Mario Ojeda-Uribe, MD, Laurence Sanhes, MD, Laurent Sutton, MD, Anne Banos, MD, Bruno Lioure, MD, Marc Bernard, MD, Didier Bouscary, MDPhD, Alain Saad, MD, Valérie Rouille, Philippe Guardiola, MD, Isabelle Luquet, MD, Marie C Bene, PharmSciD, PhD, Francois Dreyfus, MD, Jean-Yves Cahn, MD, Arnaud Pigneux, Norbert Ifrah, MD
Journal: Blood
Blood (2015) 126 (23): 3787.
https://doi.org/10.1182/blood.V126.23.3787.3787
Published: 2015
Journal Articles

Outcome of Younger Adults with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse: A Graall Study

Alexandre Desjonqueres, resident, Patrice Chevallier, MD PhD, Xavier Thomas, MD PhD, Françoise Huguet, MD, Thibault Leguay, MD, Marc Bernard, MD, Jacques-Olivier Bay, MD PhD, Emmanuelle Tavernier, MD, Aude Charbonnier, MD, Françoise Isnard, MD, Mathilde Hunault, Pascal Turlure, MD, Marc Renaud, MD, Jean-Noel M. Bastie, MD PhD, Chantal Himberlin, MD, Stephane Lepretre, MD, Bruno Lioure, MD PhD, Véronique Lhéritier, Vahid Asnafi, Kheira Beldjord, Marina Lafage, Norbert Ifrah, Herve Dombret, MD
Journal: Blood
Blood (2014) 124 (21): 931.
https://doi.org/10.1182/blood.V124.21.931.931
Published: 2014
Journal Articles

Maintenance Therapy With Alternating Azacytidine and Lenalidomide Cycles In Elderly (≥ 60) Fit Patients (Pts) With Poor Prognosis AML In First Complete Remission (CR) After Lia Induction. A Phase II Multicentric Goelams Trial

Mathilde Hunault-Berger, MD, PhD, Edouard Randriamalala, MD, Aline Schmidt-Tanguy, MD, Chantal Himberlin, MD, Bachra Choufi, MD, Caroline Bonmati, MD, Jean Yves Cahn, MD, MD marie-Anne Couturier, Eric Deconinck, MD, PhD, Jean Pierre Marolleau, MD, PhD, Frederique orisni-Piocelle, MD, Jacques Delaunay, MD, Emmanuelle Tavernier, MD, Christian Recher, MD PhD, Severine Lissandre, MD, Mario Ojeda-Uribe, MD, Laurence Sanhes, MD, Laurent Sutton, MD, Anne Banos, MD, Bruno Lioure, MD, Thierry Lamy, MD, PhD, Didier Bouscary, MD, Alain Saad, MD, Valérie Rouille, Philippe Guardiola, MD, Isabelle Luquet, MD, MD marie-Christine Bene, Francois Dreyfus, MD, Norbert Ifrah, MD, Arnaud Pigneux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2691.
https://doi.org/10.1182/blood.V122.21.2691.2691
Published: 2013
Journal Articles

Two Years Follow-up Results of Graspall/Graall-SA2–2008 Study: L-Asparaginase-Loaded Red Blood Cell Combined with Standard EWALL Chemotherapy in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL)

Mathilde Hunault-Berger, MD, PhD, Thibaut Leguay, MD, Françoise Huguet, Stéphane Leprêtre, MD, Eric Deconinck, MD, PhD, Mario Ojeda Uribe, MD, Caroline Bonmati, MD, Pierre Bories, MD, Chantal Himberlin, MD, Patrice Chevallier, MD, Philippe Rousselot, MD, PhD, Oumedaly Reman, MD, Marie-Laure Boulland, MD, Severine Lissandre, MD, Pascal Turlure, MD, Didier Bouscary, Laurence Sanhes, MD, Ollivier Legrand, MD, PhD, Isabelle Plantier, MD, Frédérique Orsini Piocelle, MD, Véronique Lhéritier, Elodie Boucher, Yann Godfrin, PhD, Norbert Ifrah, Hervé Dombret, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1473.
https://doi.org/10.1182/blood.V120.21.1473.1473
Published: 2012
Journal Articles

Equivalent Outcome Between Reduced Intensity Versus Conventional Myeloablative Conditioning Hematopoietic Stem Cell Transplantation for Patients Older Than 35 Years with Acute Myeloid Leukemia.

Marie Sebert, Raphaël Porcher, Marie Robin, Lionel Ades, MD, PhD, Emmanuel Raffoux, Alienor Xhaard, Nathalie Dhedin, MD, Jerome Larghero, Chantal Himberlin, MD, Alain Delmer, MD, Pierre Fenaux, MD, PhD, Hervé Dombret, MD, PhD, Gérard Socié, MD PhD, Regis Peffault de Latour
Journal: Blood
Blood (2012) 120 (21): 3103.
https://doi.org/10.1182/blood.V120.21.3103.3103
Published: 2012
Journal Articles

Gemtuzumab Ozogamicin-Based Salvage, Followed by Allogeneic Hematopoietic Stem Cell Transplantation, Is Highly Effective in Young Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) in First Relapse

Marie-Anne Hospital, Christian Recher, MD, PhD, Xavier Thomas, Emmanuelle Tavernier, Bruno Lioure, Cécile Pautas, Aurore Perrot, Thorsten Braun, MD, Thomas Cluzeau, Jean-Valère Malfuson, Jerome Tamburini, Céline Berthon, MD, Alexis Magda, Chantal Himberlin, Stephane de Botton, Edouard Randriamalala, Isabelle Plantier, Madalina Uzunov, Philippe Rousselot, Norbert Ifrah, Herve Dombret, Nicolas Boissel
Journal: Blood
Blood (2011) 118 (21): 2603.
https://doi.org/10.1182/blood.V118.21.2603.2603
Published: 2011
Journal Articles

Allogeneic Hematopoietic Peripheral Blood Stem-Cell Transplantation From HLA-Identical Siblings Versus Allelic-Matched Unrelated Donors (10/10 high resolution) in Patients with Acute Myeloid Leukemia and Myelodyplasic Syndrome After Reduced Intensity Conditioning,

Marie Robin, Raphael Porcher, Lionel Ades, Emmanuel Raffoux, MD, PhD, Nicolas Boissel, Jérome Larghero, Chantal Himberlin, Claude Gardin, MD, Alain Delmer, MD, Pierre Fenaux, MD, PhD, Hervé Dombret, Gérard Socié, Régis Peffault de Latour
Journal: Blood
Blood (2011) 118 (21): 4132.
https://doi.org/10.1182/blood.V118.21.4132.4132
Published: 2011
Journal Articles

Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities

Clinical Trials & Observations
Aurore Perrot, Isabelle Luquet, Arnaud Pigneux, Francine Mugneret, Jacques Delaunay, Jean-Luc Harousseau, Carole Barin, Jean-Yves Cahn, Philippe Guardiola, Chantal Himberlin, Christian Recher, Norbert Vey, Bruno Lioure, Mario Ojeda-Uribe, Nathalie Fegueux, Christian Berthou, Edouard Randriamalala, Marie C. Béné, Norbert Ifrah, Francis Witz, for the GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang)
Journal: Blood
Blood (2011) 118 (3): 679–685.
https://doi.org/10.1182/blood-2010-09-307264
Published: 2011
Journal Articles

Prognostic Value of the ‘Monosomal Karyotype’ Entity in Elderly Patients with AML: a GOELAMS Study of 186 Patients with Unfavourable Cytogenetic Abnormalities.

Aurore Perrot, MD, Isabelle Luquet, MD, PhD, Arnaud Pigneux, MD, PhD, Francine Mugneret, MD, Jacques Delaunay, MD, Jean-Luc Harousseau, MD, PhD, Francis Witz, MD, Carole Barin, MD, Jean-Yves Cahn, MD, PhD, Philippe Guardiola, MD, Chantal Himberlin, MD, Christian Recher, MD, PhD, Norbert Vey, MD, Bruno Lioure, MD, Olivier Tournilhac, MD, PhD, Nathalie Fegueux, MD, Christian Berthou, MD, PhD, Martine Escoffre-Barbe, MD, Marie-Christine Béné, MD, PhD, Norbert Ifrah, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1577.
https://doi.org/10.1182/blood.V114.22.1577.1577
Published: 2009
Journal Articles

A Phase II Study of Post–Remission Therapy with Azacitidine (AZA) in Patients with AML Post-MDS and High-Risk MDS: A GFM Group Study.

Claude Gardin, MD, Thomas Prébet, MD, Krimo Bouabdallah, MD, Denis Caillot, MD, Agnès Guerci, MD, PhD, Emmanuel Raffoux, MD, Jean Pierre Marolleau, MD, Cecile Pautas, MD, Anne Banos, MD, Chantal Himberlin, MD, Anne-Laure Taksin, MD, Arnaud Pigneux, MD, PhD, Xavier Thomas, MD, PhD, Tony Jernival, Norbert Vey, Francois Dreyfus, MD, PhD, Sylvie Chevret, PhD, Herve Dombret, MD, PhD, Pierre Fenaux
Journal: Blood
Blood (2009) 114 (22): 844.
https://doi.org/10.1182/blood.V114.22.844.844
Published: 2009
Journal Articles

Response to Azacytidine (AZA) in MDS or AML with Del 5q : Current Results of the French ATU Program

Raphael Itzykson, Sylvain Thépot, Claire Fabre, Francois Dreyfus, Bruno Quesnel, Eric Wattel, Stephane de Botton, Sylvain Pilorge, Caroline Dartigeas, Aspasia Stamatoullas, Thomas Prebet, Mario Ojeda-Uribe, Stéphane Cheze, Olivier Tournilhac, Eric Solary, Gandhi Damaj, Gerard Tertian, Chantal Himberlin, Rose-Marie Mbida, Blandine Beve, Lionel Adès, Claude Gardin, Pierre Fenaux
Journal: Blood
Blood (2008) 112 (11): 2682.
https://doi.org/10.1182/blood.V112.11.2682.2682
Published: 2008
Journal Articles

Improved Outcome with Androgens as Maintenance Treatment in Elderly Patients with Acute Myeloid Leukemia after ICL Regimen as Induction Therapy: Results of the GOELAMS SA-2002 Multicenter Phase III Randomized Open Trial

Arnaud Pigneux, MD, PhD, Chantal Himberlin, MD, Mathilde Hunault-Berger, MD, PhD, Francis Witz, MD, Christian Recher, MD, PhD, Jean-Luc Harousseau, MD, Olivier Tournilhac, MD, PhD, Christian Berthou, MD, PhD, Martine Escoffre-Barbe, MD, Denis Guyotat, MD, PhD, Nathalie Fegueux, MD, Martine Delain, MD, Bruno Lioure, MD, Eric Jourdan, MD, PhD, Didier Bouscary, MD, PhD, Laurence Legros, MD, PhD, Noel Milpied, MD, Frederic Bauduer, MD, Frederic Perry, Isabelle Luquet, MD, PhD, Marie-Christine Bene, MD, PhD, Norbert Ifrah, MD, Jean-Jacques Sotto, MD, PhD, Philippe Guardiola, MD
Journal: Blood
Blood (2008) 112 (11): 556.
https://doi.org/10.1182/blood.V112.11.556.556
Published: 2008